Bank of Montreal
RLAY icon

Bank of Montreal’s Relay Therapeutics RLAY Stock Holding History

Bank of Montreal’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$990K Sell
52,938
-5
-0% -$73 ﹤0.01% 2091
2026
Q1 		$527K Sell
52,943
-3,511
-6% -$31.4K ﹤0.01% 2369
2025
Q4 		$478K Hold
56,454
– – ﹤0.01% 2330
2025
Q3 		$295K Buy
56,454
+1,280
+2% +$4.88K ﹤0.01% 2534
2025
Q2 		$191K Buy
55,174
+23,396
+74% +$69.6K ﹤0.01% 2821
2025
Q1 		$83.3K Buy
+31,778
New +$125K ﹤0.01% 2959
2021
Q2 		– Sell
-1,767
Closed -$63K – 4698
2021
Q1 		$63K Sell
1,767
-3,221
-65% -$140K ﹤0.01% 3606
2020
Q4 		$186K Buy
4,988
+3,500
+235% +$158K ﹤0.01% 3256
2020
Q3 		$64K Buy
+1,488
New +$56.7K ﹤0.01% 3314

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of Montreal's RLAY Position: Q2 2026 in Review

Bank of Montreal reduced its Relay Therapeutics (RLAY) stake by 0.01% in Q2 2026, selling an estimated $73 and leaving 52,938 shares worth $990K. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

Bank of Montreal first reported a position in RLAY in Q3 2020 and has held it in 9 quarters since. 241 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Bank of Montreal held 52,938 shares of Relay Therapeutics worth $990K as of Q2 2026.
  • Bank of Montreal sold 5 Relay Therapeutics shares in Q2 2026, an estimated $73.
  • Relay Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2091 holding.
  • Bank of Montreal first reported a position in Relay Therapeutics in Q3 2020 and has held it in 9 quarters since.
  • 241 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.